ArticleNature communications2026
Stepwise polymerization enables tailored perovskite ink for scalable flexible perovskite solar cells.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Commercializing flexible perovskite solar cells (f-PSCs) is hindered by poor interfacial contact and suboptimal crystallization, particularly in large-area perovskite solar modules (PSMs). Here, we propose an in situ stepwise polymerization strategy utilizing an epoxy-terminated monomer (BFDGE) and a curing agent (isophorone diamine, IPDA). A room-temperature pre-reaction enables precise tailoring of perovskite ink, ensuring reliable fabrication of perovskite films over large-area substrates. Subsequently, thermal annealing synchronizes the polymerization with perovskite crystallization, dynamically modulating the crystallization process. Consequently, rigid and flexible devices yield outstanding efficiencies of 27.16% (certified 26.87%) and 25.13%, respectively. The resultant cross-linked scaffold ensures superior durability, with devices retaining 93.3% of their initial efficiency following 1000 h of maximum power point (MPP) tracking and 96% after 630 h ultraviolet irradiation. Furthermore, minimodules (10.24 cm
Identifiers
42881163What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.